Drug Profile
ONO 1608
Latest Information Update: 21 Nov 2006
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peripheral vascular disorders
Most Recent Events
- 21 Nov 2006 Discontinued - Phase-II for Peripheral vascular disorders in Japan (Injection)
- 21 Nov 2006 Discontinued - Phase-II for Peripheral vascular disorders in United Kingdom (Injection)
- 10 May 2000 New profile